Cite

HARVARD Citation

    Boddu, P. et al. (2018). Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting. Leukemia & lymphoma. 59 (6), pp. 1312-1322. [Online]. 
  
Back to record